시장보고서
상품코드
2067459

금 나노입자 시장 : 제조 공정별, 용도별, 최종 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Gold Nanoparticles Market, By Process, By Application, By End Use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 372 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 5,079,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 7,127,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 8,830,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

금 나노입자 시장 규모는 2025년에 92억 388만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 11.1%로 확대될 것으로 전망됩니다.

금 나노입자란 크기가 1-100 nm에 가까운 금 입자를 말합니다. 이들은 덩어리 형태의 금과는 완전히 다른 특정한 광학적, 전자적, 촉매적 특성을 지니고 있으며, 생의학 영상, 약물전달, 센싱 등 폭넓은 분야에서 활용되고 있습니다. 금 나노입자 시장은 맞춤형 진단 및 표적 전달 등 보다 고도화된 나노의료 응용 분야에 대한 시장 수요가 증가함에 따라 꾸준한 속도로 확대되고 있습니다. 2025년, Cytodiagnostics사는 금 나노입자 시장에서 첨단 나노의료 응용 분야의 개발을 촉진하기 위한 기술 지원 제공에 주력했습니다. 이 회사는 주로 분석법 개발 및 나노 규모의 생의학 실험에 사용되는 금 나노입자 기반 연구 플랫폼을 제공함으로써, 표적 진단 및 첨단 나노의료 응용 분야 개발의 초기 단계에 있는 개발자들로부터 신뢰를 얻었습니다. 따라서 사이트다이아그노스틱스사는 첨단 나노의료 연구 및 표적 진단 분야에서 점점 더 중요한 위치를 차지하고 있습니다.

금 나노입자 시장 - 시장 역학

생물의학 연구에 대한 자금 지원 증가가 시장 수요를 견인

생물의학 연구 자금의 증액에 따라, 특히 임상 연구와 중개과학, 나아가 헬스케어 혁신을 위한 보조금 지급이 증가하고 있습니다. 새로운 질병의 위협이 대두되고 신속한 과학적 진전이 요구되는 가운데, 연구 지원금 배분 방침은 현재 감염병 및 만성 질환에 대한 대응을 더욱 중시하는 방향으로 전환되고 있습니다. 특히, 연구 인프라 강화와 다기관 간 협력을 통한 신진 연구자에 대한 자금 지원 확충이 중시되고 있습니다.

또한, 현재 나노기술이 지닌 잠재력을 바탕으로 한 진단, 표적 약물전달, 치료법 연구 등 다양한 응용 분야에 대한 투자가 활발히 이루어지고 있는 만큼, 생의학 연구에 대한 지출도 금 나노입자 시장을 견인할 것으로 전망됩니다. 예를 들어, 인도 정부(생명공학부와 웰컴 트러스트의 파트너십)에 따르면, 인도는 생의학 연구에 대한 투자를 대폭 늘리고 있으며, 2025년 10월 현재 ‘생의학 연구 경력 프로그램(BRCP)’의 총 예산은 약 1억 8,000만 달러에 달합니다. 다양한 분야의 젊은 과학자, 박사후 연구원, 임상 연구자를 포함한 최소 2,000명의 연구자를 지원함으로써 국내 연구 인프라를 강화하기 위해 이번 투자는 생의학 연구 역량 제고와 금 나노입자를 활용한 의료 혁신 가속화를 목적으로 이루어지고 있습니다.

금 나노입자 시장 - 시장 세분화 분석:

전 세계 금 나노입자 시장은 제조 공정, 용도, 최종 용도 및 지역별로 세분화되어 있습니다.

‘제조 공정별’로 보면, 화학 합성이 금 나노입자 시장에서 큰 점유율을 차지하고 있습니다. 이는 사용 순도가 높고 입자 크기가 균일하며 대량 생산이 가능하기 때문이며, 그 결과 생의학, 진단, 나노기술 분야에서 가장 널리 활용되고 있습니다. 예를 들어, Cefic.org에 따르면 독일 화학·제약 업계의 매출액은 2,450억 달러에 달해 독일 내 3위 산업 부문으로 자리매김하고 있을 뿐만 아니라, 약 2,100개 기업에 걸쳐 약 47만 9,500명의 고용을 직접 뒷받침하고 있습니다. 이는 화학 합성에 대한 높은 의존도와 산업용 화학 생태계의 성장을 보여줍니다.

용도별로 보면 이미징은 생의학 분야의 고해상도 이미징, 암 진단에서의 조영 이미징, 질환 탐지 정확도와 민감도 향상 등 폭넓은 용도가 있어, 금 나노입자 시장에서 큰 점유율을 차지하고 있습니다. 한 예로, 2026년 Pubs.ACS Nano가 정리한 조사에 따르면, Org가 정리한 조사에 따르면, 나노입자 기반 영상 시스템의 특징은 현재 MRI, CT, 형광 영상, 광음향 영상 등 주요 생의학 영상 기법이 다양하게 공존하고 있다는 점입니다. 그러나 다중 모드 영상용 나노입자 플랫폼은 광학, 자기, X선 및 하이브리드 분자 영상 시스템을 포함한 임상적으로 관련성이 높은 4가지 이상의 주요 영상 워크플로우에서 이미 그 효과가 입증되었습니다. 따라서 이는 첨단 생의학 진단 분야에서 다중 모드 나노입자 영상 기술의 활용 확대가 정당화됨을 보여줍니다.

금 나노입자 시장 - 지역별 분석

북미는 해당 지역 내에 고도로 발달한 의료 시설 및 연구개발(R&D) 생태계가 존재하기 때문에 금 나노입자 시장에서 큰 점유율을 차지하고 있습니다. 미국병원협회(AHA)의 발표에 따르면, 2026년 시점에서 미국은 전국에 약 6,100개의 병원으로 구성된 고도로 발달된 의료 인프라를 유지하고 있으며, 대규모이자 복잡한 의료 제공 시스템의 네트워크에 의해 뒷받침되고 있습니다. 이 병원들은 총 90만 7,000개 이상의 상설 병상을 운영하고 있으며, 전미 규모의 대규모 입원 의료 체계를 구축하고 있습니다. 이 시스템은 방대한 수의 환자를 처리하고 있으며, 연간 총 입원 환자 수는 3,560만 명을 초과합니다. 이는 미국 병원 서비스의 규모와 이용 밀도가 높다는 점을 반영하고 있습니다. 따라서 수준 높은 병원과 진료소가 존재함으로써, 미세 입자를 이용한 새로운 치료법이 앞으로도 계속해서 빈번하게 활용될 것이 보장됩니다.

아시아태평양의 금 나노입자 시장은 주로 아시아 개발도상국의 의료비 증가에 힘입어 성장하고 있습니다. 예를 들어, 2025년 12월 세계은행 및 세계보건기구(WHO)의 ‘세계 의료지출 데이터베이스’에 따르면, 중국의 현재 의료지출에서 병원 및 기타 의료기관이 차지하는 비중은 여전히 32.2%에 그치고 있습니다. 그 결과, 중국 가구가 부담하는 본인부담금이 높다는 사실은 일상적인 의료비가 큰 부담이 되고 있음을 보여줍니다. GDP에서 순의료지출이 차지하는 비중은 여전히 5.9%에 그치고 있어, 사회경제 분야의 지속적인 성장을 보여주고 있습니다. 이에 따라 의료 보장 범위가 확대되고 있으며, 국내에서는 의료 인프라 및 의료 서비스 부문의 활성화와 개선을 위한 막대한 노력이 광범위한 규모로 추진되고 있습니다. 따라서 의료비 지출이 증가함에 따라, 나노기술을 활용한 첨단 의료 분야에 대한 수요도 지속적으로 높아질 것으로 예상됩니다.

영국의 금 나노입자 시장 - 국가별 분석

영국에서 금 나노입자에 대한 수요는 나노기술의 발전과 제약 산업의 성장에 힘입어 확대될 것으로 전망됩니다. 영국의 투자자들은 나노의료 관련 연구 개발에 대한 자금 지원을 늘리고 있으며, 금 나노입자는 생체 이용 가능한 약물전달체로 점점 더 많이 활용되고 있습니다. 예를 들어, 영국제약산업협회(ABPI)에 따르면, 2026년 시점에서 영국 제약 업계는 국민경제에 직접적인 총부가가치(GVA)로 약 237억 6,000만 달러를 기여하고, 연구 개발(R&D)에 약 125억 5,500만 달러를 투자했습니다. 이처럼 제약 기업이 조사 개발에 막대한 투자를 하는 것은 새로운 금 나노입자 기술의 창출로 이어지며, 그 활용 범위를 더욱 넓히는 데 기여합니다.

목차

제1장 금 나노입자 시장 개요

제2장 주요 요약

제3장 금 나노입자 주요 시장 동향

제4장 금 나노입자 산업 분석

제5장 금 나노입자 시장 : 높아지는 지정학적 긴장의 영향

제6장 금 나노입자 시장 구도

제7장 금 나노입자 시장 : 프로세스별

제8장 금 나노입자 시장 : 용도별

제9장 금 나노입자 시장 : 최종사용별

제10장 금 나노입자 시장 : 지역별

제11장 주요 벤더 분석 : 금 나노입자 산업

제12장 AnalystView의 전방위 전망

KSM

Gold Nanoparticles market size was valued at US$ 9,203.88 Million in 2025, expanding at a CAGR of 11.1% from 2026 to 2033.

Gold nanoparticles are particles of gold with a size close to 1-100 nm. They have certain optical, electronic, and catalytic properties that are entirely different from bulk gold and can be used in a wide variety of fields, including biomedical imaging, drug delivery, and sensing. The market for gold nanoparticles is expanding at a steady rate due to an increasing market demand for more sophisticated nanomedicine applications, including personalized diagnostics and targeted delivery. In 2025, Cytodiagnostics Inc. focused on providing technology support to facilitate the development of advanced nanomedicine applications in the gold nanoparticle market. They did this by providing their gold nanoparticle-based research platforms, which are predominantly used in assay development and nanoscale biomedical experiments, to gain credibility with the early developers of applications for targeted diagnostics and advanced nanomedicine. Hence, cytodiagnostics is becoming more important in advanced nanomedicine research and targeted diagnostics.

Gold Nanoparticles Market- Market Dynamics

Rising biomedical research funding driving market demand

There has been a rise in grant issuance for increasing biomedical research funding, especially for clinical research and translational science as well as healthcare innovation. Research grant protocols are now more adapted towards infectious and chronic diseases as new threats of diseases emerge demanding rapid scientific advancement. Special importance is given to a stronger research infrastructure and increased funding for young investigators through multi-institutional collaborations.

The biomedical research spending is also projected to boost the Gold Nanoparticles market as a number of investments are made in various applications, such as diagnostics, target drug delivery, and research in therapeutics in the current era, which have the potential of nanotechnology. For example, India has considerably increased investment in biomedical research, according to the Government of India (Department of Biotechnology and Wellcome Trust partnership), with the Biomedical Research Career Programme (BRCP) having a total budget of about USD 180 million in October 2025. In order to consolidate the national research infrastructure by supporting a minimum of 2,000 researchers, including early-stage scientists, post-docs, and clinical researchers from a diverse range of disciplines, this investment is put forth to enhance the biomedical research capabilities and accelerate health care innovations involving gold nanoparticles.

Gold Nanoparticles Market- Segmentation Analysis:

The Global Gold Nanoparticles market is segmented on the basis of Process, Application, End Use, and Region.

Under 'By Process,' chemical synthesis holds a significant share in the Gold Nanoparticles market because it has high usage purity with similarly sized particles and mass-producing scale; hence, it is most widely used in biomedical science, diagnostics, and nanotechnology. For instance, according to Cefic.org, Germany's chemical and pharmaceutical industry generated a turnover of USD 245,000 million, making it the third-largest industrial sector in the country while directly supporting around 479,500 jobs across ~2,100 companies. So this shows heavy dependence on chemical synthesis and the growth of industrial chemical ecosystems.

Based on application focus, imaging holds a prominent share in the gold nanoparticle market due to the broad spectrum of imaging uses, such as biomedical high-resolution imaging, contrast imaging in cancer diagnosis, enhancement in disease detection accuracy and sensitivity, and others. As an example, in 2026 it was identified by the research compiled by Pubs.ACS Nano.Org that the feature of nanoparticle-based imaging systems now represents a coexistent variety of predominant biomedical imaging modalities, including MRI, CT, fluorescence imaging, photoacoustic imaging, etc., but multimodal imaging nanoparticle platforms have already been demonstrated in more than 4 major clinically relevant imaging workflows, including optical, magnetic, X-ray, and hybrid molecular imaging systems. Thus, this supports the growing use of multimodal nanoparticle imaging in advanced biomedical diagnostics.

Gold Nanoparticles Market- Geographical Insights

North America holds a significant share in the Gold Nanoparticles market, owing to the presence of well-developed healthcare facilities and R&D ecosystems within the region. In 2026, as stated by the American Hospital Association (AHA) org., the United States maintains a highly developed healthcare infrastructure comprising approximately 6,100 hospitals nationwide, supported by a large and complex network of care delivery systems. These hospitals collectively operate more than 907,000 staffed hospital beds, enabling large-scale inpatient care capacity across the country. The system handles a significant patient load, with total annual admissions exceeding 35.6 million patients, reflecting the scale and utilization intensity of U.S. hospital services. So, good hospitals and clinics help make sure that new treatments using tiny particles keep being used often.

The Asia Pacific Gold Nanoparticles market is mainly driven by increasing healthcare expenditure in developing Asian countries. For instance, according to the recent World Bank and Global Health Expenditure database of the World Health Organization in Dec 2025, the percentage share of China's current health expenditure contributed by the hospitals and other healthcare establishments remains at 32.2%; as a result, above out-of-pocket payments by Chinese households indicate the heavy burden of day-to-day medical expenses. The net current health expenditure as a percentage of the GDP still remains at 5.9%, demonstrating continued growth in continuing increases in the socioeconomic sectors, which, hence, increase extended healthcare coverage and great efforts to promote and improve the health care infrastructure and also the health service sector at an extensive rate in the country. Hence, money is spent on healthcare; there will be ongoing demand for advanced medical uses of nanotechnology.

UK Gold Nanoparticles Market- Country Insights

The UK's demand for gold nanoparticles is predicted to grow with advances in nanotechnology along with the developed pharmaceutical industry. UK investors are funding more research on nanomedicine, and gold nanoparticles are increasingly used as bioavailable drug delivery agents. For instance, in 2026, according to the Association of the British Pharmaceutical Industry (ABPI), the UK pharmaceutical industry contributed approximately USD 23,760 million in direct gross value added (GVA) to the national economy and invested approximately USD 12,555 million in research and development (R&D). So, when drug companies invest heavily in research and development, it helps create new gold nanoparticle technologies and makes them more widely used.

Gold Nanoparticles Market- Competitive Landscape:

The competitive landscape of the gold nanoparticle industry, measured by the presence of innovative companies like Johnson Matthey, TANAKA Holdings, Merck KGaA, Cytodiagnostics, and Sona Nanotech, is strengthening its market position by developing nanoparticle synthesis, surface functionalization techniques, and high-purity products. The companies are investing in new technologies based on R&D, new personalized products, and a long-term development strategy with the pharma, diagnostics, sensing, and electronics industries. For instance, in May 2025, Sona Nanotech enhanced its gold nanorod-based Targeted Hyperthermia Therapy (THT) platform in terms of supporting clinical progression of biocompatible gold nanorods for cancer tissue treatment efficiency, thereby boosting the commercialization potential of gold nanorods technically and enhancing Sona Nanotech's market position in therapeutic nanotechnology applications. Therefore, high-quality medical nanotechnology creates more business opportunities and enhances competitive market position.

Recent Developments:

In March 2026, Metalor Technologies, a TANAKA Group company, completed the acquisition of Gannon & Scott, a North American precious metals refining and recycling company. The acquisition expands TANAKA's precious metals recycling capabilities, strengthens raw material sourcing channels, and enhances its position in gold-related materials and nanoparticle supply chains.

In May 2025, Merck KGaA announced a strategic partnership with imec to develop next-generation microphysiological systems (MPS)-on-a-chip platforms, leveraging advanced materials, nanoengineering, and AI-enabled research capabilities to improve drug discovery and preclinical testing. The partnership enhances Merck KGaA's position in advanced nanotechnology-enabled life science solutions, accelerates innovation in precision research platforms, and expands opportunities for nanoparticle-based biomedical applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GOLD NANOPARTICLES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Cytodiagnostics Inc.
  • Goldsol Inc.
  • BBI Solutions
  • NanoHybrids Inc.
  • Nanopartz Inc.
  • Nanosphere Inc.
  • Nanostellar Inc.
  • Solaris Nanosciences Corporation
  • TANAKA Holdings Co., Ltd.
  • The Metalor Group
  • Sigma-Aldrich
  • Abcam plc
  • Aurion
  • Creative Diagnostics
  • Johnson Matthey Plc
  • Meliorum Technologies Inc.
  • Merck KGaA
  • nanoComposix
  • Sona Nanotech Inc.
  • Others

GLOBAL GOLD NANOPARTICLES MARKET, BY PROCESS- MARKET ANALYSIS, 2020 - 2033

  • Chemical
  • Physical
  • Green/Biological Synthesis
  • Seed-mediated Growth
  • Continuous Flow and Microfluidic

GLOBAL GOLD NANOPARTICLES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Imaging
  • Targeted Drug Delivery
  • Proton Therapy
  • In-vitro Assays
  • Sensors, Probes
  • Catalysis
  • Others

GLOBAL GOLD NANOPARTICLES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

  • Pharmaceutical & Healthcare
  • Chemicals and Catalysts
  • Energy and Environmental
  • Electronics and Semiconductors
  • Personal Care & Cosmetics
  • Others

GLOBAL GOLD NANOPARTICLES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Gold Nanoparticles Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gold Nanoparticles Market Snippet by Process
    • 2.1.2. Gold Nanoparticles Market Snippet by Application
    • 2.1.3. Gold Nanoparticles Market Snippet by End Use
    • 2.1.4. Gold Nanoparticles Market Snippet by Country
    • 2.1.5. Gold Nanoparticles Market Snippet by Region
  • 2.2. Competitive Insights

3. Gold Nanoparticles Key Market Trends

  • 3.1. Gold Nanoparticles Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gold Nanoparticles Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gold Nanoparticles Market Opportunities
  • 3.4. Gold Nanoparticles Market Future Trends

4. Gold Nanoparticles Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gold Nanoparticles Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Gold Nanoparticles Market Landscape

  • 6.1. Gold Nanoparticles Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gold Nanoparticles Market - By Process

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Process, 2025 & 2033 (%)
    • 7.1.2. Chemical
    • 7.1.3. Physical
    • 7.1.4. Green/Biological Synthesis
    • 7.1.5. Seed-mediated Growth
    • 7.1.6. Continuous Flow and Microfluidic

8. Gold Nanoparticles Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Imaging
    • 8.1.3. Targeted Drug Delivery
    • 8.1.4. Proton Therapy
    • 8.1.5. In-vitro Assays
    • 8.1.6. Sensors, Probes
    • 8.1.7. Catalysis
    • 8.1.8. Others

9. Gold Nanoparticles Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
    • 9.1.2. Pharmaceutical & Healthcare
    • 9.1.3. Chemicals and Catalysts
    • 9.1.4. Energy and Environmental
    • 9.1.5. Electronics and Semiconductors
    • 9.1.6. Personal Care & Cosmetics
    • 9.1.7. Others

10. Gold Nanoparticles Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Gold Nanoparticles Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Gold Nanoparticles Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Gold Nanoparticles Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Gold Nanoparticles Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Gold Nanoparticles Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Gold Nanoparticles Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Cytodiagnostics Inc.
    • 11.2.2. Goldsol Inc.
    • 11.2.3. BBI Solutions
    • 11.2.4. NanoHybrids Inc.
    • 11.2.5. Nanopartz Inc.
    • 11.2.6. Nanosphere Inc.
    • 11.2.7. Nanostellar Inc.
    • 11.2.8. Solaris Nanosciences Corporation
    • 11.2.9. TANAKA Holdings Co., Ltd.
    • 11.2.10. The Metalor Group
    • 11.2.11. Sigma-Aldrich
    • 11.2.12. Abcam plc
    • 11.2.13. Aurion
    • 11.2.14. Creative Diagnostics
    • 11.2.15. Johnson Matthey Plc
    • 11.2.16. Meliorum Technologies Inc.
    • 11.2.17. Merck KGaA
    • 11.2.18. nanoComposix
    • 11.2.19. Sona Nanotech Inc.
    • 11.2.20. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기